The effects of obesity on skeletal muscle regeneration

Frontiers in Physiology

Volumn 4 DEC, Issue , 2013, Pages

  Akhmedov, Dmitry ^a   Berdeaux, Rebecca ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Leptin; Lipids; Lipotoxicity; Muscle regeneration; Obesity; Satellite cells; Skeletal muscle; Type 2 diabetes

Indexed keywords

INSULIN; LEPTIN; MYOSTATIN; PROTEIN KINASE B; SOMATOMEDIN C;

ADIPOGENESIS; AGING; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; LIPOTOXICITY; MUSCLE ATROPHY; MUSCLE GROWTH; MUSCLE INJURY; MUSCLE METABOLISM; MUSCLE REGENERATION; MYOBLAST; MYOSITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE PROGENITOR CELL; SKELETAL MUSCLE SATELLITE CELL; STEM CELL;

EID: 84891698836     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00371     Document Type: Review

References (171)

1. Adams, J. M. 2nd, Pratipanawatr, T., Berria, R., Wang, E., Defronzo, R. A., Sullards, M. C., et al. (2004). Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53, 25-31. doi: 10.2337/diabetes.53.1.25.
2. Allen, D. L., Cleary, A. S., Hanson, A. M., Lindsay, S. F., and Reed, J. M. (2010). CCAAT/enhancer binding protein-delta expression is increased in fast skeletal muscle by food deprivation and regulates myostatin transcription in vitro. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R1592-R1601. doi: 10.1152/ajpregu.00247.2010.
3. Allen, D. L., Cleary, A. S., Speaker, K. J., Lindsay, S. F., Uyenishi, J., Reed, J. M., et al. (2008). Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am. J. Physiol. Endocrinol. Metab. 294, E918-E927. doi: 10.1152/ajpendo.00798.2007.
4. Allen, D. L., Hittel, D. S., and McPherron, A. C. (2011). Expression and function of myostatin in obesity, diabetes, and exercise adaptation. Med. Sci. Sports Exerc. 43, 1828-1835. doi: 10.1249/MSS.0b013e3182178bb4.
5. Allen, D. L., and Loh, A. S. (2011). Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. Am. J. Physiol. Cell Physiol. 300, C124-C137. doi: 10.1152/ajpcell.00142.2010.
6. Allen, D. L., and Unterman, T. G. (2007). Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am. J. Physiol. Cell Physiol. 292, C188-C199. doi: 10.1152/ajpcell.00542.2005.
7. Anagnostis, P., Athyros, V. G., Tziomalos, K., Karagiannis, A., and Mikhailidis, D. P. (2009). Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J. Clin. Endocrinol. Metab. 94, 2692-2701. doi: 10.1210/jc.2009-0370.
8. Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., Van Rooijen, N., Plonquet, A., et al. (2007). Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204, 1057-1069. doi: 10.1084/jem.20070075.
9. Arounleut, P., Bowser, M., Upadhyay, S., Shi, X. M., Fulzele, S., Johnson, M. H., et al. (2013). Absence of functional leptin receptor isoforms in the POUND (Lepr(db/lb)) mouse is associated with muscle atrophy and altered myoblast proliferation and differentiation. PLoS ONE 8:e72330. doi: 10.1371/annotation/3a7d6e24-137c-4603-93ca-879bec7fab80.
10. Arsic, N., Zacchigna, S., Zentilin, L., Ramirez-Correa, G., Pattarini, L., Salvi, A., et al. (2004). Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol. Ther. 10, 844-854. doi: 10.1016/j.ymthe.2004.08.007.
11. Bikman, B. T., and Summers, S. A. (2011). Ceramides as modulators of cellular and whole-body metabolism. J. Clin. Invest. 121, 4222-4230. doi: 10.1172/JCI57144.
12. Billington, L. (1997). Reinnervation and regeneration of denervated rat soleus muscles. Muscle Nerve 20, 744-746. doi: 10.1002/(SICI)1097-4598(199706)20:6<744::AID-MUS13>3.0.CO;2-U.
13. Bloemberg, D., and Quadrilatero, J. (2012). Rapid determination of myosin heavy chain expression in rat, mouse, and human skeletal muscle using multicolor immunofluorescence analysis. PLoS ONE 7:e35273. doi: 10.1371/journal.pone.0035273.
14. Bodell, P. W., Kodesh, E., Haddad, F., Zaldivar, F. P., Cooper, D. M., and Adams, G. R. (2009). Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise. J. Appl. Physiol. 106, 443-453. doi: 10.1152/japplphysiol.90831.2008.
15. Boden, G., and Shulman, G. I. (2002). Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur. J. Clin. Invest. 32(Suppl. 3), 14-23. doi: 10.1046/j.1365-2362.32.s3.3.x.
16. Bodine, S. C. (2006). mTOR signaling and the molecular adaptation to resistance exercise. Med. Sci. Sports Exerc. 38, 1950-1957. doi: 10.1249/01.mss.0000233797.24035.35.
17. Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., et al. (2001). Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 3, 1014-1019. doi: 10.1038/ncb1101-1014.
18. Boesch, C., Machann, J., Vermathen, P., and Schick, F. (2006). Role of proton MR for the study of muscle lipid metabolism. NMR Biomed. 19, 968-988. doi: 10.1002/nbm.1096.
19. Bonen, A., Parolin, M. L., Steinberg, G. R., Calles-Escandon, J., Tandon, N. N., Glatz, J. F., et al. (2004). Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J. 18, 1144-1146. doi: 10.1096/fj.03-1065fje.
20. Bonnard, C., Durand, A., Peyrol, S., Chanseaume, E., Chauvin, M. A., Morio, B., et al. (2008). Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J. Clin. Invest. 118, 789-800. doi: 10.1172/JCI32601.
21. Bosma, M., Kersten, S., Hesselink, M. K., and Schrauwen, P. (2012). Re-evaluating lipotoxic triggers in skeletal muscle: relating intramyocellular lipid metabolism to insulin sensitivity. Prog. Lipid Res. 51, 36-49. doi: 10.1016/j.plipres.2011.11.003.
22. Broussard, S. R., McCusker, R. H., Novakofski, J. E., Strle, K., Shen, W. H., Johnson, R. W., et al. (2004). IL-1beta impairs insulin-like growth factor i-induced differentiation and downstream activation signals of the insulin-like growth factor i receptor in myoblasts. J. Immunol. 172, 7713-7720. doi: 10.1210/en.2003-0087.
23. Broussard, S. R., McCusker, R. H., Novakofski, J. E., Strle, K., Shen, W. H., Johnson, R. W., et al. (2003). Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts. Endocrinology 144, 2988-2996. doi: 10.1210/en.2003-0087.
24. Bruce, C. R., Hoy, A. J., Turner, N., Watt, M. J., Allen, T. L., Carpenter, K., et al. (2009). Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 58, 550-558. doi: 10.2337/db08-1078.
25. Bruusgaard, J. C., Johansen, I. B., Egner, I. M., Rana, Z. A., and Gundersen, K. (2010). Myonuclei acquired by overload exercise precede hypertrophy and are not lost on detraining. Proc. Natl. Acad. Sci. U.S.A. 107, 15111-15116. doi: 10.1073/pnas.0913935107.
26. Cantini, M., Massimino, M. L., Bruson, A., Catani, C., Dalla Libera, L., and Carraro, U. (1994). Macrophages regulate proliferation and differentiation of satellite cells. Biochem. Biophys. Res. Commun. 202, 1688-1696. doi: 10.1006/bbrc.1994.2129.
27. Cazzolli, R., Carpenter, L., Biden, T. J., and Schmitz-Peiffer, C. (2001). A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate. Diabetes 50, 2210-2218. doi: 10.2337/diabetes.50.10.2210.
28. Cerletti, M., Jang, Y. C., Finley, L. W., Haigis, M. C., and Wagers, A. J. (2012). Short-term calorie restriction enhances skeletal muscle stem cell function. Cell Stem Cell 10, 515-519. doi: 10.1016/j.stem.2012.04.002.
29. Charge, S. B., and Rudnicki, M. A. (2004). Cellular and molecular regulation of muscle regeneration. Physiol Rev. 84, 209-238. doi: 10.1152/physrev.00019.2003.
30. Chavez, J. A., Knotts, T. A., Wang, L. P., Li, G., Dobrowsky, R. T., Florant, G. L., et al. (2003). A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J. Biol. Chem. 278, 10297-10303. doi: 10.1074/jbc.M212307200.
31. Coen, P. M., and Goodpaster, B. H. (2012). Role of intramyocelluar lipids in human health. Trends Endocrinol. Metab. 23, 391-398. doi: 10.1016/j.tem.2012.05.009.
32. d'Albis, A., Couteaux, R., Janmot, C., Roulet, A., and Mira, J. C. (1988). Regeneration after cardiotoxin injury of innervated and denervated slow and fast muscles of mammals. Myosin isoform analysis. Eur. J. Biochem. 174, 103-110. doi: 10.1111/j.1432-1033.1988.tb14068.x.
33. De Larichaudy, J., Zufferli, A., Serra, F., Isidori, A. M., Naro, F., Dessalle, K., et al. (2012). TNF-alpha-and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism. Skelet. Muscle 2, 2. doi: 10.1186/2044-5040-2-2.
34. Deasy, B. M., Feduska, J. M., Payne, T. R., Li, Y., Ambrosio, F., and Huard, J. (2009). Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol. Ther. 17, 1788-1798. doi: 10.1038/mt.2009.136.
35. Deng, B., Wehling-Henricks, M., Villalta, S. A., Wang, Y., and Tidball, J. G. (2012). IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J. Immunol. 189, 3669-3680. doi: 10.4049/jimmunol.1103180.
36. Fissoune, R., Janier, M., Briguet, A., and Hiba, B. (2009). In vivo assessment of mouse hindleg intramyocellular lipids by 1H-MR spectroscopy. Acad. Radiol. 16, 890-896. doi: 10.1016/j.acra.2008.12.007.
37. Frost, R. A., Lang, C. H., and Gelato, M. C. (1997). Transient exposure of human myoblasts to tumor necrosis factor-alpha inhibits serum and insulin-like growth factor-I stimulated protein synthesis. Endocrinology 138, 4153-4159. doi: 10.1210/en.138.10.4153.
38. Fujimoto, T., Ohsaki, Y., Cheng, J., Suzuki, M., and Shinohara, Y. (2008). Lipid droplets: a classic organelle with new outfits. Histochem. Cell. Biol. 130, 263-279. doi: 10.1007/s00418-008-0449-0.
39. Fulco, M., Cen, Y., Zhao, P., Hoffman, E. P., McBurney, M. W., Sauve, A. A., et al. (2008). Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev. Cell. 14, 661-673. doi: 10.1016/j.devcel.2008.02.004.
40. Fulco, M., Schiltz, R. L., Iezzi, S., King, M. T., Zhao, P., Kashiwaya, Y., et al. (2003). Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol. Cell. 12, 51-62. doi: 10.1016/S1097-2765(03)00226-0.
41. Gibson, M. C., and Schultz, E. (1983). Age-related differences in absolute numbers of skeletal muscle satellite cells. Muscle Nerve 6, 574-580. doi: 10.1002/mus.880060807.
42. Glass, D., and Roubenoff, R. (2010). Recent advances in the biology and therapy of muscle wasting. Ann. N.Y. Acad. Sci. 1211, 25-36. doi: 10.1111/j.1749-6632.2010.05809.x.
43. Glass, D. J. (2010). PI3 kinase regulation of skeletal muscle hypertrophy and atrophy. Curr. Top. Microbiol. Immunol. 346, 267-278. doi: 10.1007/82_2010_78.
44. Goodpaster, B. H., Thaete, F. L., and Kelley, D. E. (2000a). Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am. J. Clin. Nutr. 71, 885-892.
45. Goodpaster, B. H., Theriault, R., Watkins, S. C., and Kelley, D. E. (2000b). Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 49, 467-472. doi: 10.1016/S0026-0495(00)80010-4.
46. Goodpaster, B. H., and Wolf, D. (2004). Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes. Pediatr. Diabetes 5, 219-226. doi: 10.1111/j.1399-543X.2004.00071.x.
47. Greenhalgh, D. G. (2003). Wound healing and diabetes mellitus. Clin. Plast. Surg. 30, 37-45. doi: 10.1016/S0094-1298(02)00066-4.
48. Gregor, M. F., and Hotamisligil, G. S. (2011). Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415-445. doi: 10.1146/annurev-immunol-031210-101322.
49. Gunther, S., Kim, J., Kostin, S., Lepper, C., Fan, C. M., and Braun, T. (2013). Myf5-Positive Satellite Cells Contribute to Pax7-Dependent Long-Term Maintenance of Adult Muscle Stem Cells. Cell Stem Cell. 13, 590-601. doi: 10.1016/j.stem.2013.07.016.
50. Hajduch, E., Balendran, A., Batty, I. H., Litherland, G. J., Blair, A. S., Downes, C. P., et al. (2001). Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 44, 173-183. doi: 10.1007/s001250051596.
51. Han, D. S., Huang, H. P., Wang, T. G., Hung, M. Y., Ke, J. Y., Chang, K. T., et al. (2010). Transcription activation of myostatin by trichostatin A in differentiated C2C12 myocytes via ASK1-MKK3/4/6-JNK and p38 mitogen-activated protein kinase pathways. J. Cell. Biochem. 111, 564-573. doi: 10.1002/jcb.22740.
52. Henique, C., Mansouri, A., Fumey, G., Lenoir, V., Girard, J., Bouillaud, F., et al. (2010). Increased mitochondrial fatty acid oxidation is sufficient to protect skeletal muscle cells from palmitate-induced apoptosis. J. Biol. Chem. 285, 36818-36827. doi: 10.1074/jbc.M110.170431.
53. Heredia, J. E., Mukundan, L., Chen, F. M., Mueller, A. A., Deo, R. C., Locksley, R. M., et al. (2013). Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 153, 376-388. doi: 10.1016/j.cell.2013.02.053.
54. Hilton, T. N., Tuttle, L. J., Bohnert, K. L., Mueller, M. J., and Sinacore, D. R. (2008). Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function. Phys. Ther. 88, 1336-1344. doi: 10.2522/ptj.20080079.
55. Hittel, D. S., Berggren, J. R., Shearer, J., Boyle, K., and Houmard, J. A. (2009). Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes 58, 30-38. doi: 10.2337/db08-0943.
56. Holland, W. L., Brozinick, J. T., Wang, L. P., Hawkins, E. D., Sargent, K. M., Liu, Y., et al. (2007). Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 5, 167-179. doi: 10.1016/j.cmet.2007.01.002.
57. Hu, Z., Wang, H., Lee, I. H., Modi, S., Wang, X., Du, J., et al. (2010). PTEN inhibition improves muscle regeneration in mice fed a high-fat diet. Diabetes 59, 1312-1320. doi: 10.2337/db09-1155.
58. Hulver, M. W., Berggren, J. R., Cortright, R. N., Dudek, R. W., Thompson, R. P., Pories, W. J., et al. (2003). Skeletal muscle lipid metabolism with obesity. Am. J. Physiol. Endocrinol. Metab. 284, E741-E747. doi: 10.1152/ajpendo.00514.2002.
59. Hyde, R., Hajduch, E., Powell, D. J., Taylor, P. M., and Hundal, H. S. (2005). Ceramide down-regulates System A amino acid transport and protein synthesis in rat skeletal muscle cells. FASEB J. 19, 461-463. doi: 10.1096/fj.04-2284fje.
60. Jackson, J. R., Mula, J., Kirby, T. J., Fry, C. S., Lee, J. D., Ubele, M. F., et al. (2012). Satellite cell depletion does not inhibit adult skeletal muscle regrowth following unloading-induced atrophy. Am. J. Physiol. Cell. Physiol. 303, C854-C861. doi: 10.1152/ajpcell.00207.2012.
61. Jang, Y. C., Sinha, M., Cerletti, M., Dall'osso, C., and Wagers, A. J. (2011). Skeletal muscle stem cells: effects of aging and metabolism on muscle regenerative function. Cold Spring Harb. Symp. Quant. Biol. 76, 101-111. doi: 10.1101/sqb.2011.76.010652.
62. Joe, A. W., Yi, L., Natarajan, A., Le Grand, F., So, L., Wang, J., Rudnicki, M. A., et al. (2010). Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat. Cell. Biol. 12, 153-163. doi: 10.1038/ncb2015.
63. Joulia-Ekaza, D., and Cabello, G. (2006). Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects. Exp. Cell. Res. 312, 2401-2414. doi: 10.1016/j.yexcr.2006.04.012.
64. Joulia, D., Bernardi, H., Garandel, V., Rabenoelina, F., Vernus, B., and Cabello, G. (2003). Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp. Cell. Res. 286, 263-275. doi: 10.1016/S0014-4827(03)00074-0.
65. Kadi, F., Schjerling, P., Andersen, L. L., Charifi, N., Madsen, J. L., Christensen, L. R., et al. (2004). The effects of heavy resistance training and detraining on satellite cells in human skeletal muscles. J. Physiol. 558, 1005-1012. doi: 10.1113/jphysiol.2004.065904.
66. Kahn, S. E., Hull, R. L., and Utzschneider, K. M. (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846. doi: 10.1038/nature05482.
67. Kellerer, M., Koch, M., Metzinger, E., Mushack, J., Capp, E., and Haring, H. U. (1997). Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia 40, 1358-1362. doi: 10.1007/s001250050832.
68. Kharraz, Y., Guerra, J., Mann, C. J., Serrano, A. L., and Munoz-Canoves, P. (2013). Macrophage plasticity and the role of inflammation in skeletal muscle repair. Mediators Inflamm. 2013, 491497. doi: 10.1155/2013/491497.
69. Kim, Y. B., Uotani, S., Pierroz, D. D., Flier, J. S., and Kahn, B. B. (2000). In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology 141, 2328-2339. doi: 10.1210/en.141.7.2328.
70. Kollias, H. D., and McDermott, J. C. (2008). Transforming growth factor-beta and myostatin signaling in skeletal muscle. J. Appl. Physiol. 104, 579-587. doi: 10.1152/japplphysiol.01091.2007.
71. Kuhlmann, J., Neumann-Haefelin, C., Belz, U., Kalisch, J., Juretschke, H. P., Stein, M., et al. (2003). Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats. Diabetes 52, 138-144. doi: 10.2337/diabetes.52.1.138.
72. Kurtz, T. W., Morris, R. C., and Pershadsingh, H. A. (1989). The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 13, 896-901. doi: 10.1161/01.HYP.13.6.896.
73. Kusminski, C. M., Shetty, S., Orci, L., Unger, R. H., and Scherer, P. E. (2009). Diabetes and apoptosis: lipotoxicity. Apoptosis 14, 1484-1495. doi: 10.1007/s10495-009-0352-8.
74. Langen, R. C., Schols, A. M., Kelders, M. C., Van Der Velden, J. L., Wouters, E. F., and Janssen-Heininger, Y. M. (2006). Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation. Am. J. Respir. Cell Mol. Biol. 35, 689-696. doi: 10.1165/rcmb.2006-0103OC.
75. Langen, R. C., Schols, A. M., Kelders, M. C., Wouters, E. F., and Janssen-Heininger, Y. M. (2001). Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J. 15, 1169-1180. doi: 10.1096/fj.00-0463.
76. Langley, B., Thomas, M., Bishop, A., Sharma, M., Gilmour, S., and Kambadur, R. (2002). Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J. Biol. Chem. 277, 49831-49840. doi: 10.1074/jbc.M204291200.
77. Lavie, C. J., Milani, R. V., and Ventura, H. O. (2009). Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J. Am. Coll. Cardiol. 53, 1925-1932. doi: 10.1016/j.jacc.2008.12.068.
78. Layne, M. D., and Farmer, S. R. (1999). Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts. Exp. Cell Res. 249, 177-187. doi: 10.1006/excr.1999.4465.
79. Lee, S., Kim, Y., White, D. A., Kuk, J. L., and Arslanian, S. (2012a). Relationships between insulin sensitivity, skeletal muscle mass and muscle quality in obese adolescent boys. Eur. J. Clin. Nutr. 66, 1366-1368. doi: 10.1038/ejcn.2012.142.
80. Lee, S. J., Huynh, T. V., Lee, Y. S., Sebald, S. M., Wilcox-Adelman, S. A., Iwamori, N., et al. (2012b). Role of satellite cells versus myofibers in muscle hypertrophy induced by inhibition of the myostatin/activin signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 109, E2353-E2360. doi: 10.1073/pnas.1206410109.
81. Lee, S. Y., Kim, J. R., Ha, M. Y., Shim, S. M., and Park, T. S. (2013). Measurements of diacylglycerols in skeletal muscle by atmospheric pressure chemical ionization mass spectrometry. Lipids 48, 287-296. doi: 10.1007/s11745-013-3766-6.
82. Lelliott, C., and Vidal-Puig, A. J. (2004). Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation. Int. J. Obes. Relat. Metab. Disord. 28(Suppl. 4), S22-S28. doi: 10.1038/sj.ijo.0802854.
83. Lepper, C., Partridge, T. A., and Fan, C. M. (2011). An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration. Development 138, 3639-3646. doi: 10.1242/dev.067595.
84. Lesault, P. F., Theret, M., Magnan, M., Cuvellier, S., Niu, Y., Gherardi, R. K., et al. (2012). Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into MDX skeletal muscle. PLoS ONE 7:e46698. doi: 10.1371/journal.pone.0046698.
85. Levak-Frank, S., Radner, H., Walsh, A., Stollberger, R., Knipping, G., Hoefler, G., et al. (1995). Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J. Clin. Invest. 96, 976-986. doi: 10.1172/JCI118145.
86. Li, Y., Soos, T. J., Li, X., Wu, J., Degennaro, M., Sun, X., et al. (2004). Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101). J. Biol. Chem. 279, 45304-45307. doi: 10.1074/jbc.C400186200.
87. Li, Y. P. (2003). TNF-alpha is a mitogen in skeletal muscle. Am. J. Physiol. Cell Physiol. 285, C370-C376. doi: 10.1152/ajpcell.00453.2002.
88. Liu, D., Black, B. L., and Derynck, R. (2001). TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev. 15, 2950-2966. doi: 10.1101/gad.925901.
89. Madaro, L., Pelle, A., Nicoletti, C., Crupi, A., Marrocco, V., Bossi, G., et al. (2012). PKC theta ablation improves healing in a mouse model of muscular dystrophy. PLoS ONE 7:e31515. doi: 10.1371/journal.pone.0031515.
90. Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., et al. (1995). Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1, 1155-1161. doi: 10.1038/nm1195-1155.
91. Magnusson, Y. K., Friberg, P., Sjovall, P., Malm, J., and Chen, Y. (2008). TOF-SIMS analysis of lipid accumulation in the skeletal muscle of ob/ob mice. Obesity (Silver Spring) 16, 2745-2753. doi: 10.1038/oby.2008.424.
92. Malenfant, P., Joanisse, D. R., Theriault, R., Goodpaster, B. H., Kelley, D. E., and Simoneau, J. A. (2001). Fat content in individual muscle fibers of lean and obese subjects. Int. J. Obes. Relat. Metab. Disord. 25, 1316-1321. doi: 10.1038/sj.ijo.0801733.
93. Mann, C. J., Perdiguero, E., Kharraz, Y., Aguilar, S., Pessina, P., Serrano, A. L., et al. (2011). Aberrant repair and fibrosis development in skeletal muscle. Skelet. Muscle 1, 21. doi: 10.1186/2044-5040-1-21.
94. Marino, J. S., Hinds, T. D. Jr., Potter, R. A., Ondrus, E., Onion, J. L., Dowling, A., et al. (2013). Suppression of protein kinase C theta contributes to enhanced myogenesis in vitro via IRS1 and ERK1/2 phosphorylation. BMC Cell Biol. 14:39. doi: 10.1186/1471-2121-14-39.
95. Maroni, P., Bendinelli, P., and Piccoletti, R. (2003). Early intracellular events induced by in vivo leptin treatment in mouse skeletal muscle. Mol. Cell Endocrinol. 201, 109-121. doi: 10.1016/S0303-7207(02)00427-6.
96. Maroni, P., Bendinelli, P., and Piccoletti, R. (2005). Intracellular signal transduction pathways induced by leptin in C2C12 cells. Cell. Biol. Int. 29, 542-550. doi: 10.1016/j.cellbi.2005.03.008.
97. Marotta, M., Ferrer-Martnez, A., Parnau, J., Turini, M., Mace, K., and Gomez Foix, A. M. (2004). Fiber type-and fatty acid composition-dependent effects of high-fat diets on rat muscle triacylglyceride and fatty acid transporter protein-1 content. Metabolism 53, 1032-1036. doi: 10.1016/j.metabol.2004.03.011.
98. Martin, S. S., Qasim, A., and Reilly, M. P. (2008). Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J. Am. Coll. Cardiol. 52, 1201-1210. doi: 10.1016/j.jacc.2008.05.060.
99. Massimino, M. L., Rapizzi, E., Cantini, M., Libera, L. D., Mazzoleni, F., Arslan, P., et al. (1997). ED2+ macrophages increase selectively myoblast proliferation in muscle cultures. Biochem. Biophys. Res. Commun. 235, 754-759. doi: 10.1006/bbrc.1997.6823.
100. McCarthy, J. J., Mula, J., Miyazaki, M., Erfani, R., Garrison, K., Farooqui, A. B., et al. (2011). Effective fiber hypertrophy in satellite cell-depleted skeletal muscle. Development 138, 3657-3666. doi: 10.1242/dev.068858.
101. McCroskery, S., Thomas, M., Maxwell, L., Sharma, M., and Kambadur, R. (2003). Myostatin negatively regulates satellite cell activation and self-renewal. J. Cell. Biol. 162, 1135-1147. doi: 10.1083/jcb.200207056.
102. Mebarek, S., Komati, H., Naro, F., Zeiller, C., Alvisi, M., Lagarde, M., et al. (2007). Inhibition of de novo ceramide synthesis upregulates phospholipase D and enhances myogenic differentiation. J. Cell. Sci. 120, 407-416. doi: 10.1242/jcs.03331.
103. Merly, F., Lescaudron, L., Rouaud, T., Crossin, F., and Gardahaut, M. F. (1999). Macrophages enhance muscle satellite cell proliferation and delay their differentiation. Muscle Nerve 22, 724-732. doi: 10.1002/(SICI)1097-4598(199906)22:6<724::AID-MUS9^gt;3.0.CO;2-O.
104. Messina, S., Mazzeo, A., Bitto, A., Aguennouz, M., Migliorato, A., De Pasquale, M. G., et al. (2007). VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice. FASEB J. 21, 3737-3746. doi: 10.1096/fj.07-8459com.
105. Miller, S. C., Ito, H., Blau, H. M., and Torti, F. M. (1988). Tumor necrosis factor inhibits human myogenesis in vitro. Mol. Cell Biol. 8, 2295-2301.
106. Mittendorfer, B., Magkos, F., Fabbrini, E., Mohammed, B. S., and Klein, S. (2009). Relationship between body fat mass and free fatty acid kinetics in men and women. Obesity (Silver Spring) 17, 1872-1877. doi: 10.1038/oby.2009.224.
107. Nguyen, M. H., Cheng, M., and Koh, T. J. (2011). Impaired muscle regeneration in ob/ob and db/db mice. ScientificWorldJournal 11, 1525-1535. doi: 10.1100/tsw.2011.137.
108. Ochoa, O., Sun, D., Reyes-Reyna, S. M., Waite, L. L., Michalek, J. E., McManus, L. M., et al. (2007). Delayed angiogenesis and VEGF production in CCR2-/-mice during impaired skeletal muscle regeneration. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R651-R661. doi: 10.1152/ajpregu.00069.2007.
109. Paturi, S., Gutta, A. K., Kakarla, S. K., Katta, A., Arnold, E. C., Wu, M., et al. (2010). Impaired overload-induced hypertrophy in obese Zucker rat slow-twitch skeletal muscle. J. Appl. Physiol. 108, 7-13. doi: 10.1152/japplphysiol.00330.2009.
110. Penton, C. M., Thomas-Ahner, J. M., Johnson, E. K., McAllister, C., and Montanaro, F. (2013). Muscle side population cells from dystrophic or injured muscle adopt a fibro-adipogenic fate. PLOS ONE 8:e54553. doi: 10.1371/journal.pone.0054553.
111. Peterson, J. M., Bryner, R. W., and Alway, S. E. (2008a). Satellite cell proliferation is reduced in muscles of obese Zucker rats but restored with loading. Am. J. Physiol. Cell Physiol. 295, C521-C528. doi: 10.1152/ajpcell.00073.2008.
112. Peterson, J. M., Wang, Y., Bryner, R. W., Williamson, D. L., and Alway, S. E. (2008b). Bax signaling regulates palmitate-mediated apoptosis in C(2)C(12) myotubes. Am. J. Physiol. Endocrinol. Metab. 295, E1307-E1314. doi: 10.1152/ajpendo.00738.2007.
113. Petrella, J. K., Kim, J. S., Mayhew, D. L., Cross, J. M., and Bamman, M. M. (2008). Potent myofiber hypertrophy during resistance training in humans is associated with satellite cell-mediated myonuclear addition: a cluster analysis. J. Appl. Physiol. (1985) 104, 1736-1742. doi: 10.1152/japplphysiol.01215.2007.
114. Pijet, M., Pijet, B., Litwiniuk, A., Pajak, B., Gajkowska, B., and Orzechowski, A. (2013). Leptin impairs myogenesis in C2C12 cells through JAK/STAT and MEK signaling pathways. Cytokine 61, 445-454. doi: 10.1016/j.cyto.2012.11.002.
115. Powell, D. J., Hajduch, E., Kular, G., and Hundal, H. S. (2003). Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism. Mol. Cell Biol. 23, 7794-7808. doi: 10.1128/MCB.23.21.7794-7808.2003.
116. Powell, D. J., Turban, S., Gray, A., Hajduch, E., and Hundal, H. S. (2004). Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem. J. 382, 619-629. doi: 10.1042/BJ20040139.
117. Purchas, R. W., Romsos, D. R., Allen, R. E., and Merkel, R. A. (1985). Muscle growth and satellite cell proliferative activity in obese (OB/OB) mice. J. Anim. Sci. 60, 644-651.
118. Rachek, L. I., Musiyenko, S. I., Ledoux, S. P., and Wilson, G. L. (2007). Palmitate induced mitochondrial deoxyribonucleic acid damage and apoptosis in l6 rat skeletal muscle cells. Endocrinology 148, 293-299. doi: 10.1210/en.2006-0998.
119. Radley, H. G., De Luca, A., Lynch, G. S., and Grounds, M. D. (2007). Duchenne muscular dystrophy: focus on pharmaceutical and nutritional interventions. Int. J. Biochem. Cell Biol. 39, 469-477. doi: 10.1016/j.biocel.2006.09.009.
120. Raso, G. M., Pacilio, M., Esposito, E., Coppola, A., Di Carlo, R., and Meli, R. (2002). Leptin potentiates IFN-gamma-induced expression of nitric oxide synthase and cyclo-oxygenase-2 in murine macrophage J774A.1. Br. J. Pharmacol. 137, 799-804. doi: 10.1038/sj.bjp.0704903.
121. Rodrigues Ade, C., and Schmalbruch, H. (1995). Satellite cells and myonuclei in long-term denervated rat muscles. Anat. Rec. 243, 430-437. doi: 10.1002/ar.1092430405.
122. Rosenblatt, J. D., Yong, D., and Parry, D. J. (1994). Satellite cell activity is required for hypertrophy of overloaded adult rat muscle. Muscle Nerve 17, 608-613. doi: 10.1002/mus.880170607.
123. Ryall, J. G. (2012). The role of sirtuins in the regulation of metabolic homeostasis in skeletal muscle. Curr. Opin. Clin. Nutr. Metab. Care 15, 561-566. doi: 10.1097/MCO.0b013e3283590914.
124. Ryall, J. G. (2013). Metabolic reprogramming as a novel regulator of skeletal muscle development and regeneration. FEBS J 280, 4004-4013. doi: 10.1111/febs.12189.
125. Sainz, N., Rodriguez, A., Catalan, V., Becerril, S., Ramirez, B., Gomez-Ambrosi, J., et al. (2009). Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice. PLoS ONE 4:e6808. doi: 10.1371/journal.pone.0006808.
126. Salehian, B., Mahabadi, V., Bilas, J., Taylor, W. E., and Ma, K. (2006). The effect of glutamine on prevention of glucocorticoid-induced skeletal muscle atrophy is associated with myostatin suppression. Metabolism 55, 1239-1247. doi: 10.1016/j.metabol.2006.05.009.
127. Salinas, M., Lopez-Valdaliso, R., Martin, D., Alvarez, A., and Cuadrado, A. (2000). Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells. Mol. Cell. Neurosci. 15, 156-169. doi: 10.1006/mcne.1999.0813.
128. Samuel, V. T., Petersen, K. F., and Shulman, G. I. (2010). Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375, 2267-2277. doi: 10.1016/S0140-6736(10)60408-4.
129. Samuel, V. T., and Shulman, G. I. (2012). Mechanisms for insulin resistance: common threads and missing links. Cell 148, 852-871. doi: 10.1016/j.cell.2012.02.017.
130. Santos-Alvarez, J., Goberna, R., and Sanchez-Margalet, V. (1999). Human leptin stimulates proliferation and activation of human circulating monocytes. Cell. Immunol. 194, 6-11. doi: 10.1006/cimm.1999.1490.
131. Sartorelli, V., and Fulco, M. (2004). Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy. Sci. STKE 2004, re11. doi: 10.1126/stke.2442004re11.
132. Simoneau, J. A., Colberg, S. R., Thaete, F. L., and Kelley, D. E. (1995). Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J. 9, 273-278.
133. Sinha, R., Dufour, S., Petersen, K. F., Lebon, V., Enoksson, S., Ma, Y. Z., et al. (2002). Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 51, 1022-1027. doi: 10.2337/diabetes.51.4.1022.
134. Sishi, B., Loos, B., Ellis, B., Smith, W., Du Toit, E. F., and Engelbrecht, A. M. (2011). Diet-induced obesity alters signalling pathways and induces atrophy and apoptosis in skeletal muscle in a prediabetic rat model. Exp. Physiol. 96, 179-193. doi: 10.1113/expphysiol.2010.054189.
135. Sitnick, M., Bodine, S. C., and Rutledge, J. C. (2009). Chronic high fat feeding attenuates load-induced hypertrophy in mice. J. Physiol. 587, 5753-5765. doi: 10.1113/jphysiol.2009.180174.
136. Spiller, M. P., Kambadur, R., Jeanplong, F., Thomas, M., Martyn, J. K., Bass, J. J., et al. (2002). The myostatin gene is a downstream target gene of basic helix-loop-helix transcription factor MyoD. Mol. Cell Biol. 22, 7066-7082. doi: 10.1128/MCB.22.20.7066-7082.2002.
137. Stratford, S., Hoehn, K. L., Liu, F., and Summers, S. A. (2004). Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B. J. Biol. Chem. 279, 36608-36615. doi: 10.1074/jbc.M406499200.
138. Strle, K., Broussard, S. R., McCusker, R. H., Shen, W. H., Johnson, R. W., Freund, G. G., et al. (2004). Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide. Endocrinology 145, 4592-4602. doi: 10.1210/en.2003-1749.
139. Tamilarasan, K. P., Temmel, H., Das, S. K., Al Zoughbi, W., Schauer, S., Vesely, P. W., et al. (2012). Skeletal muscle damage and impaired regeneration due to LPL-mediated lipotoxicity. Cell Death Dis. 3, e354. doi: 10.1038/cddis.2012.91.
140. Taylor, W. E., Bhasin, S., Artaza, J., Byhower, F., Azam, M., Willard, D. H. Jr., et al. (2001). Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am. J. Physiol. Endocrinol. Metab. 280, E221-E228.
141. Thiele, C., and Spandl, J. (2008). Cell biology of lipid droplets. Curr. Opin. Cell Biol. 20, 378-385. doi: 10.1016/j.ceb.2008.05.009.
142. Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., et al. (2000). Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J. Biol. Chem. 275, 40235-40243. doi: 10.1074/jbc.M004356200.
143. Timmers, S., Schrauwen, P., and De Vogel, J. (2008). Muscular diacylglycerol metabolism and insulin resistance. Physiol. Behav. 94, 242-251. doi: 10.1016/j.physbeh.2007.12.002.
144. Torrente, Y., El Fahime, E., Caron, N. J., Del Bo, R., Belicchi, M., Pisati, F., et al. (2003). Tumor necrosis factor-alpha (TNF-alpha) stimulates chemotactic response in mouse myogenic cells. Cell Transplant. 12, 91-100. doi: 10.3727/000000003783985115.
145. Toth, K. G., McKay, B. R., De Lisio, M., Little, J. P., Tarnopolsky, M. A., and Parise, G. (2011). IL-6 induced STAT3 signalling is associated with the proliferation of human muscle satellite cells following acute muscle damage. PLoS ONE 6:e17392. doi: 10.1371/journal.pone.0017392.
146. Trendelenburg, A. U., Meyer, A., Jacobi, C., Feige, J. N., and Glass, D. J. (2012). TAK-1/p38/nNFkappaB signaling inhibits myoblast differentiation by increasing levels of Activin A. Skelet. Muscle 2, 3. doi: 10.1186/2044-5040-2-3.
147. Tschop, M., and Heiman, M. L. (2001). Rodent obesity models: an overview. Exp. Clin. Endocrinol. Diabetes 109, 307-319. doi: 10.1055/s-2001-17297.
148. Turban, S., and Hajduch, E. (2011). Protein kinase C isoforms: mediators of reactive lipid metabolites in the development of insulin resistance. FEBS Lett. 585, 269-274. doi: 10.1016/j.febslet.2010.12.022.
149. Turinsky, J., Bayly, B. P., and O'Sullivan, D. M. (1990). 1,2-Diacylglycerol and ceramide levels in rat skeletal muscle and liver in vivo. Studies with insulin, exercise, muscle denervation, and vasopressin. J. Biol. Chem. 265, 7933-7938.
150. Turner, N., Kowalski, G. M., Leslie, S. J., Risis, S., Yang, C., Lee-Young, R. S., et al. (2013). Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 56, 1638-1648. doi: 10.1007/s00125-013-2913-1.
151. Turpin, S. M., Lancaster, G. I., Darby, I., Febbraio, M. A., and Watt, M. J. (2006). Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance. Am. J. Physiol. Endocrinol. Metab. 291, E1341-E1350. doi: 10.1152/ajpendo.00095.2006.
152. Turpin, S. M., Ryall, J. G., Southgate, R., Darby, I., Hevener, A. L., Febbraio, M. A., et al. (2009). Examination of 'lipotoxicity' in skeletal muscle of high-fat fed and ob/ob mice. J. Physiol. 587, 1593-1605. doi: 10.1113/jphysiol.2008.166033.
153. Uezumi, A., Fukada, S., Yamamoto, N., Takeda, S., and Tsuchida, K. (2010). Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat. Cell Biol. 12, 143-152. doi: 10.1038/ncb2014.
154. Unger, R. H. (2003). Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144, 5159-5165. doi: 10.1210/en.2003-0870.
155. Unger, R. H., Clark, G. O., Scherer, P. E., and Orci, L. (2010). Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim. Biophys. Acta 1801, 209-214. doi: 10.1016/j.bbalip.2009.10.006.
156. Ussher, J. R., Koves, T. R., Cadete, V. J., Zhang, L., Jaswal, J. S., Swyrd, S. J., et al. (2010). Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes 59, 2453-2464. doi: 10.2337/db09-1293.
157. Van Herpen, N. A., and Schrauwen-Hinderling, V. B. (2008). Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol. Behav. 94, 231-241. doi: 10.1016/j.physbeh.2007.11.049.
158. Vincent, A. M., Callaghan, B. C., Smith, A. L., and Feldman, E. L. (2011). Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat. Rev. Neurol. 7, 573-583. doi: 10.1038/nrneurol.2011.137.
159. Wang, X., Wu, H., Zhang, Z., Liu, S., Yang, J., Chen, X., et al. (2008). Effects of interleukin-6, leukemia inhibitory factor, and ciliary neurotrophic factor on the proliferation and differentiation of adult human myoblasts. Cell Mol. Neurobiol. 28, 113-124. doi: 10.1007/s10571-007-9247-9.
160. Wang, Y. X., and Rudnicki, M. A. (2012). Satellite cells, the engines of muscle repair. Nat. Rev. Mol. Cell Biol. 13, 127-133. doi: 10.1038/nrm3265.
161. Warren, G. L., Hulderman, T., Mishra, D., Gao, X., Millecchia, L., O'Farrell, L., et al. (2005). Chemokine receptor CCR2 involvement in skeletal muscle regeneration. FASEB J. 19, 413-415. doi: 10.1096/fj.04-2421fje.
162. Warren, G. L., Summan, M., Gao, X., Chapman, R., Hulderman, T., and Simeonova, P. P. (2007). Mechanisms of skeletal muscle injury and repair revealed by gene expression studies in mouse models. J. Physiol. 582, 825-841. doi: 10.1113/jphysiol.2007.132373.
163. Watts, R., McAinch, A. J., Dixon, J. B., O'Brien, P. E., and Cameron-Smith, D. (2013). Increased Smad signaling and reduced MRF expression in skeletal muscle from obese subjects. Obesity (Silver Spring) 21, 525-528. doi: 10.1002/oby.20070.
164. Wellen, K. E., and Hotamisligil, G. S. (2005). Inflammation, stress, and diabetes. J. Clin. Invest. 115, 1111-1119. doi: 10.1172/JCI200525102.
165. Will, K., Kalbe, C., Kuzinski, J., Losel, D., Viergutz, T., Palin, M. F., et al. (2012). Effects of leptin and adiponectin on proliferation and protein metabolism of porcine myoblasts. Histochem. Cell Biol. 138, 271-287. doi: 10.1007/s00418-012-0949-9.
166. Woo, M., Isganaitis, E., Cerletti, M., Fitzpatrick, C., Wagers, A. J., Jimenez-Chillaron, J., et al. (2011). Early life nutrition modulates muscle stem cell number: implications for muscle mass and repair. Stem Cells Dev. 20, 1763-1769. doi: 10.1089/scd.2010.0349.
167. World Health Organization. (2013). Obesity and overweight Fact Sheet N°311. WHO Media Centre. Geneva, Switzerland.
168. Ye, Q., Danzer, C. F., Fuchs, A., Krek, W., Mueggler, T., Baltes, C., et al. (2011). Longitudinal evaluation of intramyocellular lipids (IMCLs) in tibialis anterior muscle of ob/ob and ob/+ control mice using a cryogenic surface coil at 9.4 T. NMR Biomed. 24, 1295-1301. doi: 10.1002/nbm.1691.
169. Ylitalo, K. R., Sowers, M., and Heeringa, S. (2011). Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity: National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 34, 1642-1647. doi: 10.2337/dc10-2150.
170. Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., et al. (2002). Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277, 50230-50236. doi: 10.1074/jbc.M200958200.
171. Yuzefovych, L., Wilson, G., and Rachek, L. (2010). Different effects of oleate vs. palmitate on mitochondrial function, apoptosis, and insulin signaling in L6 skeletal muscle cells: role of oxidative stress. Am. J. Physiol. Endocrinol. Metab. 299, E1096-E1105. doi: 10.1152/ajpendo.00238.2010.